Page last updated: 2024-09-03

4-(alpha-(4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl)-n,n-diethylbenzamide and Nerve Pain

4-(alpha-(4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl)-n,n-diethylbenzamide has been researched along with Nerve Pain in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dolle, RE; Gavériaux-Ruff, C; Kieffer, BL; Le Bourdonnec, B; Little, PJ; Nozaki, C; Reiss, D; Windh, RT1

Other Studies

1 other study(ies) available for 4-(alpha-(4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl)-n,n-diethylbenzamide and Nerve Pain

ArticleYear
δ-Opioid mechanisms for ADL5747 and ADL5859 effects in mice: analgesia, locomotion, and receptor internalization.
    The Journal of pharmacology and experimental therapeutics, 2012, Volume: 342, Issue:3

    Topics: Analgesia; Analgesics, Opioid; Animals; Benzamides; Benzopyrans; Disease Models, Animal; Gene Knock-In Techniques; Humans; Inflammation; Locomotion; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; NAV1.8 Voltage-Gated Sodium Channel; Neuralgia; Neurons; Pain Measurement; Piperazines; Receptors, Opioid, delta; Spiro Compounds

2012